MindBio Therapeutics Corp. (CNSX: MBIO)
Health Care · Biotechnology · CA
CA$0.13
-3.85% today · -96.9% 1Y
MindBio Therapeutics Corp. (CNSX: MBIO) operates in the Biotechnology industry within the Health Care sector. The company is valued at $643.60K.
Over the last twelve months the share price has lost 96.9%, trading between 0.12 and 4.00.
Tweenvest scores MindBio Therapeutics Corp. across four factors: quality 11/100, value 22/100. Its strongest factor is value.
MBIO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $643.60K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.13
- Dividend yield
- —
- Beta (5Y)
- -0.78
- 52-week high
- CA$4.00
- 52-week low
- CA$0.12
- Avg volume (3M)
- —
- Shares outstanding
- 7.28M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Helix BioMedix, Inc.OTCPK: HXBM | $739.29K | $— | — |
| Smart Agro - LimitedTASE: SMAG | $731.90K | ₪0.54 | -1.29% |
| Nutra Pharma Corp.OTCPK: NPHC | $715.97K | $0.00 | +9900.00% |
| SQZ Biotechnologies CompanyOTCPK: SQZB | $707.79K | $0.02 | -0.41% |
| Tessera Defense and Homeland Security Inc.NYSEAM: HLSQ | $609.88K | $0.22 | -21.61% |
| Ludwig Enterprises, Inc.OTCPK: LUDG | $585.08K | $0.00 | -30.00% |
| Orgenesis Inc.OTCPK: ORGS | $555.63K | $0.06 | -83.80% |
| Entheon Biomedical Corp.CNSX: ENBI.X | $538.87K | CA$0.06 | -21.43% |
Figures last refreshed Oct 18, 2026.